- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01252485
Registry Study on Patient Characteristics, Biological Disease Profile and Clinical Outcome in Acute Myeloid Leukemia and Related Neoplasms - The Biology and Outcome (BiO)-Project (AMLSG BiO)
December 29, 2025 updated by: Prof. Dr. Hartmut Doehner, University of Ulm
This is a registry study in adult patients with newly diagnosed or refractory/relapsed myeloid neoplasms
Investigator's sites: 80-90 sites in Germany and Austria
Estimated duration of observation of an individual patient:
10 years maximum
Objectives
- To register all patients with AML and related neoplasms, newly diagnosed or relapsed/refractory in all AMLSG participating centers (completeness)
- To perform rapid analyses of disease-related genetic markers (incidences, treatment recommendations)
- To assess patient and family history, as well as patient characteristics
- To evaluate treatment response (CR, CRh, CRi) and outcome data (event-free survival [EFS], relapse-free survival [RFS], cumulative incidence of relapse [CIR], cumulative incidence of death [CID], overall survival [OS])
- To evaluate the impact of measurable residual disease (MRD) by different methods
- To assess biological disease features and correlate with clinical outcome data (prognostic and predictive markers)
- To store biosamples from all patients (e.g., bone marrow, blood, plasma, normal tissue; e.g., skin biopsy, finger nails, hairs, sputum, or urine)
Study Overview
Status
Recruiting
Conditions
Study Type
Observational
Enrollment (Estimated)
50000
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Hartmut Döhner, Prof. Dr.
- Phone Number: 49-731-500-45501
- Email: hartmut.doehner@uniklinik-ulm.de
Study Locations
-
-
-
Graz, Austria, 8036
- Recruiting
- Medizinische Universität Graz
-
Contact:
- Armin Zebisch, Prof. Dr.
-
Innsbruck, Austria, 6020
- Recruiting
- Medizinische Universität Innsbruck
-
Contact:
- David Nachbaur, Prof. Dr.
-
Linz, Austria
- Recruiting
- Kepler Universitatsklinikum GmbH
-
Contact:
- Clemens Schmitt, Prof.
-
Linz, Austria, 4020
- Recruiting
- Krankenhaus der Elisabethinen Linz GmbH
-
Contact:
- Michael Girschikofsky, Dr.
-
Linz, Austria, 4010
- Suspended
- Krankenhaus der Barmherzigen Schwestern Linz Betriebsgesellschaft m.b.H.
-
Rankweil, Austria, 6807
- Recruiting
- Landeskrankenhaus Feldkirch
-
Contact:
- Bernd Hartmann, Dr.
-
Salzburg, Austria
- Recruiting
- Universitätsklinikum der PMU Landeskrankenhaus Salzburg
-
Contact:
- Lisa Pleyer
-
Vienna, Austria, 1140
- Recruiting
- Hanuschkrankenhaus Wien
-
Contact:
- Elisabeth Koller, Dr.
-
-
-
-
-
Aschaffenburg, Germany, 63739
- Recruiting
- Klinikum Aschaffenburg
-
Contact:
- Manfred Welslau, Dr.
-
Augsburg, Germany, 86156
- Suspended
- Klinikum Augsburg
-
Aurich, Germany, 26603
- Suspended
- Ubbo-Emmius-Klinik Aurich
-
Bad Saarow, Germany, 15526
- Recruiting
- Helios Klinikum Bad Saarow
-
Contact:
- Daniel Schöndube, Dr.med.
-
Berlin, Germany
- Recruiting
- Helios Klinikum Emil Von Behring
-
Contact:
- Immanuel Merz
-
Berlin, Germany, 10967
- Recruiting
- Vivantes Klinikum Am Urban
-
Contact:
- Annette Dieing, Dr.
-
Berlin, Germany, 12351
- Recruiting
- Vivantes Netzwerk für Gesundheit GmbH Klinikum Neukölln
-
Contact:
- Maike De Wit, Prof. Dr. med.
-
Berlin, Germany, 13353
- Recruiting
- Charite Universitatsmedizin Berlin Campus Virchow Klinikum
-
Contact:
- Jörg Westermann, PD Dr.
-
Berlin, Germany
- Recruiting
- Vivantes Klinikum Spandau
-
Contact:
- Joerg-Christian Rath, Dr.
-
Bochum, Germany, 44892
- Recruiting
- Medizinische Universitätsklinik Knappschaftskrankenhaus Bochum
-
Contact:
- Roland Schroers, Prof. Dr.
-
Bochum, Germany, 44791
- Recruiting
- Augusta-Kranken-Anstalt
-
Contact:
- Stefan Lukic, Dr.
-
Bonn, Germany, 53105
- Recruiting
- Universitätsklinikum Bonn
-
Contact:
- Lino Teichmann, Dr.
-
Braunschweig, Germany, 38114
- Recruiting
- Städtisches Klinikum Braunschweig
-
Contact:
- Jürgen Krauter, Prof. Dr.
-
Bremen, Germany, 28177
- Recruiting
- Klinikum Bremen-Mitte gGmbH
-
Contact:
- Maher Hanoun, Prof. Dr. med.
-
Darmstadt, Germany, 64283
- Recruiting
- Klinikum Darmstadt
-
Contact:
- Helga Bernhard, Prof. Dr. med.
-
Dortmund, Germany, 44137
- Recruiting
- St. Johannes Hospital
-
Contact:
- Darina Kodzahbasheva, Dr.
-
Düsseldorf, Germany, 40225
- Recruiting
- Universitätsklinikum Düsseldorf
-
Contact:
- Ulrich Germing, Prof.
-
Düsseldorf, Germany
- Recruiting
- Marien Hospital Dusseldorf GMBH
-
Contact:
- Stefanie Groepper, Dr.
-
Essen, Germany, 45239
- Recruiting
- Kliniken Essen-Süd Evang. Krankenhaus Essen-Werden gGmbH
-
Contact:
- Peter Reimer, Prof. Dr.
-
Esslingen am Neckar, Germany, 73730
- Recruiting
- Klinikum Esslingen GmbH
-
Contact:
- Swen Wessendorf, PD Dr.
-
Flensburg, Germany, 24939
- Recruiting
- St. Franziskus Hospital
-
Contact:
- Nicolai Faber, dr
-
Frankfurt, Germany, 65929
- Recruiting
- Städtische Kliniken Frankfurt am Main-Höchst
-
Contact:
- Felicitas Scholten, Dr. med.
-
Freiburg im Breisgau, Germany, 79106
- Recruiting
- Medizinische Universitätsklinik
-
Contact:
- Michael Lübbert, Prof. Dr.
-
Fulda, Germany, 36043
- Suspended
- MVZ Osthessen Medizinisches Versorgungszentrum
-
Giessen, Germany, 35385
- Recruiting
- Klinik der Justus-Liebig-Universität
-
Contact:
- Maisun Abu Samra, Dr.
-
Goch, Germany, 47574
- Recruiting
- Wilhelm-Anton-Hospital gGmbH
-
Contact:
- Volker Runde, Prof. Dr. med.
-
Greifswald, Germany
- Recruiting
- Universitätsmedizin Greifswald
-
Contact:
- Adrian Schwarzer, Prof.
-
Göppingen, Germany, 73035
- Recruiting
- Alb Fils Kliniken GmbH
-
Contact:
- Martin Bommer, PD Dr.
-
Göttingen, Germany, 37075
- Recruiting
- Universitatsmedizin Gottingen
-
Contact:
- Gerald Wulf, Prof. Dr.
-
Halle, Germany
- Recruiting
- Universitätsklinikum Hall
-
Contact:
- Michael Heuser
-
Hamburg, Germany, 22763
- Recruiting
- Asklepios Klinik Altona
-
Contact:
- Hans Salwender, Dr.
-
Hamburg, Germany, 20246
- Recruiting
- Universitätsklinikum Hamburg-Eppendorf
-
Contact:
- Franziska Westendorf, Dr.
-
Hamburg, Germany
- Recruiting
- Asklepios Kliniken Hamburg GmbH St. Georg
-
Contact:
- Ahmet Elmaagacli, Prof.
-
Hamm, Germany, 59063
- Recruiting
- Evangelisches Krankenhaus Hamm
-
Contact:
- Alexander Baraniskin, Dr.
-
Hanau, Germany, 63450
- Recruiting
- Klinikum Hanau gGmbH
-
Contact:
- Huesameddin Yildirim, Dr.
-
Hanover, Germany, 30625
- Recruiting
- Medizinische Hochschule Hannover
-
Contact:
- Felicitas Thol, PD Dr.
-
Hanover, Germany, 30449
- Recruiting
- Klinikum Hannover Siloah
-
Contact:
- Kim Marienhagen, Dr.
-
Heilbronn, Germany, 74078
- Recruiting
- SLK-Kliniken Heilbronn GmbH
-
Contact:
- Uwe Martens, Prof. Dr.
-
Herne, Germany, 44625
- Recruiting
- Marienhospital Herne Klinikum der Ruhr-Universität Bochum
-
Contact:
- Dirk Strumberg, Prof. Dr.
-
Homburg/Saar, Germany, 66424
- Recruiting
- Universitätsklinikum des Saarlandes
-
Contact:
- Joerg Bittingbring, Dr.
-
Kaiserslautern, Germany, 67655
- Recruiting
- Westpfalz-Klinikum Kaiserslautern
-
Contact:
- Gerhard HELD, Prof.
-
Karlsruhe, Germany, 76133
- Recruiting
- Stadtisches Klinikum Karlsruhe
-
Contact:
- Martin Bentz, Prof. Dr.
-
Karlsruhe, Germany, 76137
- Recruiting
- St. Vincentius-Kliniken Karlsruhe
-
Contact:
- Martina Gnadler
-
Kassel, Germany, 34125
- Active, not recruiting
- Klinikum Kassel Gmbh
-
Kiel, Germany, 24116
- Suspended
- Städtisches Krankenhaus Kiel GmbH
-
Krefeld, Germany
- Recruiting
- Helios Klinikum Krefeld
-
Contact:
- Ali Nuri Hünerlitürkoglu, Dr.
-
Landshut, Germany, 84034
- Recruiting
- Klinikum Landshut gGmbH
-
Contact:
- Christian Bogner, Dr.
-
Lebach, Germany, 66822
- Recruiting
- Caritas Krankenhaus Lebach
-
Contact:
- Stephan Kremers, Dr. med.
-
Lemgo, Germany, 32657
- Recruiting
- Klinikum Lippe-Lemgo
-
Contact:
- Frank Hartmann, Prof. Dr. med.
-
Ludwigshafen, Germany, 67063
- Recruiting
- Klinikum der Stadt Ludwigshafen am Rhein gGmbH
-
Contact:
- Martin Hoffmann, Dr.
-
Lübeck, Germany, 23538
- Recruiting
- Universitätslinikum Schleswig-Holstein, Lübeck
-
Contact:
- Friederike Wortmann, Dr.
-
Lüdenscheid, Germany, 58515
- Recruiting
- Klinikum Lüdenscheid
-
Contact:
- Monika Schwalenberg, Dr.
-
Magdeburg, Germany, 39120
- Recruiting
- Univ-Klinikum der Otto-von-Guericke-Universität
-
Contact:
- Ana Maria Waldleben
-
Magdeburg, Germany, 39130
- Recruiting
- Klinikum Magdeburg gGmbH
-
Contact:
- Christian Plate, Dr.
-
Mainz, Germany, 55131
- Recruiting
- Universitätsklinikum der Johannes Gutenberg-Universität Mainz
-
Contact:
- Michael Kuehn, Dr.
-
Meschede, Germany, 59872
- Recruiting
- Klinikum Hochsauerland GmbH
-
Contact:
- Mohammad Wattad, Dr.
-
Minden, Germany, 32429
- Recruiting
- Johannes Wesling Klinikum Minden
-
Contact:
- Kai Wille, Dr.
-
Mutlangen, Germany, 73557
- Recruiting
- Klinikum Schwäbisch-Gmünd
-
Contact:
- Holger Hebart, Prof. Dr. med.
-
Mühlheim, Germany, 45466
- Recruiting
- Evangelisches Krankenhaus Mülheim an der Ruhr GmbH
-
Contact:
- Jan Schröder, Dr.
-
München, Germany, 81675
- Recruiting
- Klinikum rechts der Isar der TU München
-
Contact:
- Katharina Götze, Prof. Dr.
-
München, Germany, 80804
- Suspended
- Klinikum Schwabing
-
Neuss, Germany, 41464
- Suspended
- Städtische Kliniken Neuss Lukaskrankenhaus GmbH
-
Offenbach, Germany, 63069
- Recruiting
- Sana Klinikum Offenbach
-
Contact:
- Alexander Burchardt
-
Offenburg, Germany, 77654
- Recruiting
- Ortenau Klinikum, Offenburg-Gengenbach
-
Contact:
- Irmgard Dresel, Dr.
-
Oldenburg, Germany, 26121
- Recruiting
- Pius Hospital Oldenburg
-
Contact:
- Frank Griesinger, Prof. Dr.
-
Oldenburg, Germany, 26133
- Recruiting
- Klinikum Oldenburg gGmbH
-
Contact:
- Andreas Voss, Dr.
-
Passau, Germany, 94032
- Recruiting
- Klinikum Passau
-
Contact:
- Thomas Südhoff, Prof. Dr.
-
Potsdam, Germany, 14467
- Recruiting
- Ernst-von-Bergmann-Klinikum Potsdam gGmbH
-
Contact:
- Su Hyeon Kim, Dr.
-
Recklinghausen, Germany, 45657
- Recruiting
- Klinikum Vest
-
Contact:
- Michael Klein, Dr.
-
Regensburg, Germany, 93053
- Recruiting
- Universitätsklinikum
-
Contact:
- Hendrik Poeck, Prof. Dr.
-
Rostock, Germany
- Recruiting
- University Hospital Rostock
-
Contact:
- Christian Junghanss
-
Saarbrücken, Germany, 66113
- Recruiting
- Akademisches Lehrkrankenhaus des Saarlandes St. Theresia
-
Contact:
- Julian Alexis Topaly
-
Saarlouis, Germany
- Recruiting
- Marienhaus Klinikum St. Elisaeth Saarlouis
-
Contact:
- Katharina Graeber, Dr.
-
Sande, Germany
- Recruiting
- Nordwest-Krankenhaus Sanderbusch
-
Contact:
- Detlev Kohl, Dr
-
Stuttgart, Germany, 70176
- Recruiting
- Diakonie-Klinikum Stuttgart
-
Contact:
- Jochen Greiner, Prof. Dr.
-
Stuttgart, Germany, 70174
- Recruiting
- Klinikum Stuttgart Katharinenhospital
-
Contact:
- Jan Schleicher, Dr. med.
-
Stuttgart, Germany, 70199
- Recruiting
- Vinzenz von Paul Kliniken gGmbH Marienhospital Stuttgart
-
Contact:
- Christian Jehn, Prof. Dr.
-
Traunstein, Germany, 83278
- Recruiting
- Klinikum Traunstein
-
Contact:
- Thomas Kubin, Dr. med.
-
Trier, Germany, 54292
- Recruiting
- Krankenhaus der Barmherzigen Brüder Trier
-
Contact:
- Iordanis Deligiannis, Dr.
-
Trier, Germany, 54290
- Recruiting
- Klinikum Mutterhaus der Borromäerinnen gGmbH
-
Contact:
- Tobias Buss, Dr. med.
-
Tübingen, Germany, 72076
- Recruiting
- Medizinische Universitätsklinik Tübingen
-
Contact:
- Claudia Lengerke, Prof.
-
Ulm, Germany, 89081
- Recruiting
- University Hospital of Ulm
-
Contact:
- Hartmut Döhner, Prof. Dr.
- Phone Number: 49-731-500-45501
- Email: hartmut.doehner@uniklinik-ulm.de
-
Ulm, Germany, 89081
- Recruiting
- Universitätsklinik Ulm Labor für Zytogenetische und Molekulare Diagnostik
-
Contact:
- Konstanze Döhner, Prof. Dr.
-
Villingen-Schwenningen, Germany, 78052
- Recruiting
- Schwarzwald-Baar Klinikum Villingen-Schwenningen GmbH
-
Contact:
- Paul Graf La Rosee, Prof. Dr.
-
Wernigerode, Germany, 38855
- Recruiting
- Harzklinikum Dorothea Christiane Erxleben
-
Contact:
- Heiko Hütten
-
Wuppertal, Germany, 42283
- Recruiting
- Helios Klinikum Wuppertal
-
Contact:
- Silke Schostok, Dr.
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
14 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
patients with newly diagnosed or relapsed/refractory AML in all AMLSG participating centers (80-90 centers in Germany and Austria)
Description
Inclusion Criteria:
- Patients with suspected diagnosis of acute myeloid leukemia and related neoplasms, newly diagnosed or relapsed/refractory, classified according to the International Consensus Classification
- Age ≥ 18 years. There is no upper age limit.
- Signed written informed consent
Exclusion Criteria:
- Severe neurological or psychiatric disorder interfering with ability to give an informed consent
- No consent for registration, storage and processing of the individual patient and disease characteristics and course as well as information of the family physician about study participation
- No consent for biobanking of patient's biological specimens and performance of analyses on stored material.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Case-Only
- Time Perspectives: Prospective
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Event-free survival
Time Frame: 10 years
|
To assess patient and family history, patient characteristics and outcome data (event-free survival [EFS], cumulative incidence of relapse [CIR], cumulative incidence of death [CID], overall survival [OS])
|
10 years
|
|
Cumulative incidence of relapse
Time Frame: 10 years
|
To assess patient and family history, patient characteristics and outcome data (event-free survival [EFS], cumulative incidence of relapse [CIR], cumulative incidence of death [CID], overall survival [OS])
|
10 years
|
|
Cumulative incidence of death
Time Frame: 10 years
|
To assess patient and family history, patient characteristics and outcome data (event-free survival [EFS], cumulative incidence of relapse [CIR], cumulative incidence of death [CID], overall survival [OS])
|
10 years
|
|
Overall survival
Time Frame: 10 years
|
To assess patient and family history, patient characteristics and outcome data (event-free survival [EFS], cumulative incidence of relapse [CIR], cumulative incidence of death [CID], overall survival [OS])
|
10 years
|
|
Geographical representation
Time Frame: 1 day
|
Geographical representation of patients through collection of patients zip codes
|
1 day
|
|
incidence of disease-related genetic markers
Time Frame: 4 weeks
|
To perform rapid analyses of disease-related genetic markers (according to International Consensus Classification 2022) (incidences, treatment recommendations)
|
4 weeks
|
|
Treatment decision (intensive, non-intensive, investigational)
Time Frame: 1 year
|
To perform rapid analyses of disease-related genetic markers (according to ICC 2022) (incidences, treatment recommendations)
|
1 year
|
|
quality of life
Time Frame: 2 years
|
Quality of life assessed by the EORTC Quality of Life Core Questionnaire (QLQ-C30), supplemented by information on self-assessed concomitant diseases, late treatment effects, socioeconomics, and demographics according to Messerer D et al (2008), 6, 12 and 24 months after registration.
|
2 years
|
|
Response to therapy
Time Frame: 1 year
|
Rate of response: complete remission (CR), CR with partial hematologic recovery (CRh); CR with incomplete hematologic recovery (CRi)
|
1 year
|
|
Relapse-free survival
Time Frame: 10 years
|
10 years
|
|
|
Measurable residual disease (MRD)
Time Frame: 10 years
|
10 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Chair: Hartmut Döhner, Prof. Dr., University Hospital of Ulm
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 6, 2010
Primary Completion (Estimated)
December 31, 2044
Study Completion (Estimated)
December 31, 2044
Study Registration Dates
First Submitted
December 2, 2010
First Submitted That Met QC Criteria
December 2, 2010
First Posted (Estimated)
December 3, 2010
Study Record Updates
Last Update Posted (Estimated)
January 5, 2026
Last Update Submitted That Met QC Criteria
December 29, 2025
Last Verified
December 1, 2025
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- AMLSG BiO
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Acute Myeloid Leukemia (AML)
-
Daiichi Sankyo, Inc.CompletedAMLUnited States, Korea, Republic of, Taiwan, United Kingdom, France, Australia, Spain, Italy, Canada, Singapore, Germany, Netherlands, Hong Kong, Belgium, Croatia, Czechia, Hungary, Poland, Serbia
-
Gemin XCompleted
-
Peking University People's HospitalRecruitingAcute Myeloid Leukemia (AML) | Relapsed/Refractory Acute Myeloid Leukemia (AML) | High Risk Acute Myeloid Leukemia(AML)China
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.RecruitingNewly Diagnosed Acute Myeloid Leukemia (AML)China
-
Goethe UniversityCompleted
-
The First Affiliated Hospital of Soochow UniversityRecruitingAcute Myeloid Leukemia (AML) in RemissionChina
-
Grupo Argentino de Tratamiento de la Leucemia AgudaCompleted
-
Shanghai Jiao Tong University School of MedicineWashington University School of Medicine; Fred Hutchinson Cancer Center; Leiden...Not yet recruitingAcute Myeloid Leukemia (AML) | Refractory Acute Myeloid Leukemia (AML) | Relapse Acute Myeloid LeukemiaChina
-
AstraZenecaTerminatedRelapsed or Refractory Acute Myeloid Leukemia (AML)United States
-
University of Colorado, DenverNot yet recruitingMyelodysplastic Syndrome | Relapsed Acute Myeloid Leukemia (AML) | Refractory Acute Myeloid Leukemia (AML) | AML (Acute Myeloid Leukemia)United States